Truist Securities Maintains Buy on Exponent, Lowers Price Target to $95-Report Released on 1 February 2024
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Tobey Sommer maintains a Buy rating on Exponent (NASDAQ:EXPO) but lowers the price target from $110 to $95 as of 1 February 2024.

February 02, 2024 | 7:53 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities maintains a Buy rating on Exponent but lowers the price target from $110 to $95.
While the reduction in price target could suggest a tempered outlook on Exponent's short-term price potential, the maintenance of a Buy rating indicates continued confidence in the company's fundamentals and long-term growth prospects. This mixed signal could lead to neutral short-term price movement as investors weigh the lowered price target against the sustained positive rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100